Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research

Li Ning1,2, Jiahui Xi1,2, Yin Zi1,2

  • 1Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, South China Institute of Large Animal Models for Biomedicine, School of Biotechnology and Health Science, Wuyi University, Jiangmen, China.

Clinical Genetics
|September 14, 2023
PubMed

Insights

Clustered regularly interspaced palindromic repeat (CRISPR)/Cas9 gene editing advances cancer research by enabling the study of gene mutations. This technology holds potential for developing novel cancer therapies and disease models.

Area of Science:

  • Oncology
  • Genetics
  • Biotechnology

Background:

  • Cancer arises from gene mutations and expression dysregulation.
  • Gene editing offers a powerful tool to investigate cancer-related genes.

Purpose of the Study:

  • To review the mechanisms and advancements of CRISPR/Cas9 gene-editing technology.
  • To explore CRISPR/Cas9 applications in cancer research, including disease models, gene therapy, and immunotherapy.

Main Methods:

  • Review of recent literature on CRISPR/Cas9 technology.
  • Analysis of CRISPR/Cas9 applications in cancer research.

Main Results:

  • CRISPR/Cas9 technology allows precise editing of cancer-related genes.
  • Potential applications include creating human tumor models and advancing gene and immunotherapies.

Conclusions:

  • CRISPR/Cas9 is a transformative technology for understanding cancer mechanisms.
  • It offers promising avenues for developing innovative cancer treatments and diagnostics.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.2K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
48
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
74.3K